BioLASCO Taiwan Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	73.15	80.71	106.82	142.97	168.5	201.17
Short-Term Investments	55.7	55.7	55.7	58.7	58.7	43.3
Cash & Short-Term Investments	128.85	136.41	162.52	201.67	227.2	244.47
Cash Growth	-15.14%	-16.07%	-19.41%	-11.24%	-7.06%	-0.12%
Accounts Receivable	43.01	37.08	44.48	49.41	31.35	30.51
Receivables	43.01	37.08	44.48	49.41	31.35	30.51
Inventory	26.98	30.13	37.84	34.3	26.22	19.34
Prepaid Expenses	-	-	1.03	1.04	0.8	0.71
Other Current Assets	7.72	7.49	3.41	3.43	1.76	2.06
Total Current Assets	206.57	211.11	249.28	289.84	287.34	297.08
Property, Plant & Equipment	249.72	250.08	237.64	190.71	197.13	199.35
Long-Term Investments	118.43	121.24	116.94	83.29	72.76	64.51
Other Intangible Assets	0.16	0.19	0.33	0.34	0.46	0.1
Long-Term Deferred Tax Assets	2.38	2.36	1.99	2.65	4.29	5.25
Other Long-Term Assets	9.29	7.6	6.48	6.3	7.71	7.98
Total Assets	586.55	592.58	612.67	573.14	569.69	574.26
Accounts Payable	6.89	5.25	19.61	5.49	8.44	5.67
Accrued Expenses	-	-	17.97	17.74	16.55	15.91
Current Portion of Long-Term Debt	12.6	-	11.27	5.33	5.33	5.33
Current Portion of Leases	0.9	0.97	1.14	1.44	2.41	0.83
Current Income Taxes Payable	3	1.71	5.1	10.6	9.63	10.69
Current Unearned Revenue	6.72	6.73	1.65	7.77	3.96	2.66
Other Current Liabilities	58.43	39.03	11.36	11.69	10.1	9.06
Total Current Liabilities	88.54	53.69	68.1	60.07	56.42	50.14
Long-Term Debt	76.42	79.44	94.52	51.28	56.61	61.94
Long-Term Leases	0.84	1.07	0.08	0.16	1.6	1.07
Pension & Post-Retirement Benefits	-	-	-	-	-	0.44
Long-Term Deferred Tax Liabilities	0.71	0.66	0.59	0.48	0.43	0.32
Total Liabilities	166.51	134.86	163.29	111.98	115.05	113.91
Common Stock	256.12	256.12	256.12	256.12	256.12	256.12
Additional Paid-In Capital	84.12	84.12	95.64	95.64	102.04	102.04
Retained Earnings	107.25	141.58	125.7	123.6	105.81	104.01
Comprehensive Income & Other	-27.45	-24.11	-28.09	-14.21	-9.34	-1.82
Total Common Equity	420.05	457.72	449.38	461.16	454.64	460.36
Shareholders' Equity	420.05	457.72	449.38	461.16	454.64	460.36
Total Liabilities & Equity	586.55	592.58	612.67	573.14	569.69	574.26
Total Debt	90.76	81.49	107.01	58.21	65.95	69.18
Net Cash (Debt)	38.09	54.92	55.51	143.46	161.26	175.29
Net Cash Growth	-13.77%	-1.06%	-61.31%	-11.04%	-8.01%	2.73%
Net Cash Per Share	-	2.14	2.16	5.59	6.28	6.83
Filing Date Shares Outstanding	-	26.02	25.61	25.61	25.61	25.61
Total Common Shares Outstanding	-	26.02	25.61	25.61	25.61	25.61
Working Capital	118.04	157.42	181.19	229.78	230.92	246.94
Book Value Per Share	-	17.59	17.55	18.01	17.75	17.97
Tangible Book Value	419.89	457.53	449.05	460.82	454.18	460.26
Tangible Book Value Per Share	-	17.58	17.53	17.99	17.73	17.97
Land	-	-	149.68	117.39	117.39	117.39
Buildings	-	-	114.09	102.5	102.5	102.5
Machinery	-	-	28.35	25.4	24.22	23.52
Construction In Progress	-	-	5.6	-	-	-
Leasehold Improvements	-	-	-	0.38	-	5.32